肝细胞癌化疗后栓塞治疗的益处与潜在副作用

C. Siloşi, M. Boldeanu, A. Andritoiu, M. Cojocaru, L. Boldeanu, C. Avramescu, I. Siloși
{"title":"肝细胞癌化疗后栓塞治疗的益处与潜在副作用","authors":"C. Siloşi, M. Boldeanu, A. Andritoiu, M. Cojocaru, L. Boldeanu, C. Avramescu, I. Siloși","doi":"10.52701/MONC.2020.V1I1.7","DOIUrl":null,"url":null,"abstract":"It is known that, among chronic liver diseases, the most common cause of morbidity and/or mortality is hepatocellular carcinoma. Due to the fact that most patients are diagnosed with advanced disease, surgical resection is no longer possible. These patients constitute the ideal group for transarterial chemoembolization, which consists of the local infusion of a mixture of chemotherapeutic agents, which will cause the suppression of blood supply of the cancerous lesions, the induction of ischemia, followed by the necrosis of the tumor tissue, with a considerable improvement in the survival rate.","PeriodicalId":299951,"journal":{"name":"Medico Oncology","volume":"96 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"THE BENEFITS VS POTENTIAL SIDE EFFECTS OF POSTCHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA\",\"authors\":\"C. Siloşi, M. Boldeanu, A. Andritoiu, M. Cojocaru, L. Boldeanu, C. Avramescu, I. Siloși\",\"doi\":\"10.52701/MONC.2020.V1I1.7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It is known that, among chronic liver diseases, the most common cause of morbidity and/or mortality is hepatocellular carcinoma. Due to the fact that most patients are diagnosed with advanced disease, surgical resection is no longer possible. These patients constitute the ideal group for transarterial chemoembolization, which consists of the local infusion of a mixture of chemotherapeutic agents, which will cause the suppression of blood supply of the cancerous lesions, the induction of ischemia, followed by the necrosis of the tumor tissue, with a considerable improvement in the survival rate.\",\"PeriodicalId\":299951,\"journal\":{\"name\":\"Medico Oncology\",\"volume\":\"96 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medico Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52701/MONC.2020.V1I1.7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medico Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52701/MONC.2020.V1I1.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

众所周知,在慢性肝病中,最常见的发病和/或死亡原因是肝细胞癌。由于大多数患者被诊断为疾病晚期,手术切除已不再可能。这些患者构成了经动脉化疗栓塞的理想群体,经动脉化疗栓塞由局部输注混合化疗药物组成,会使癌变灶的血供受到抑制,引起局部缺血,进而使肿瘤组织坏死,生存率有相当的提高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
THE BENEFITS VS POTENTIAL SIDE EFFECTS OF POSTCHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
It is known that, among chronic liver diseases, the most common cause of morbidity and/or mortality is hepatocellular carcinoma. Due to the fact that most patients are diagnosed with advanced disease, surgical resection is no longer possible. These patients constitute the ideal group for transarterial chemoembolization, which consists of the local infusion of a mixture of chemotherapeutic agents, which will cause the suppression of blood supply of the cancerous lesions, the induction of ischemia, followed by the necrosis of the tumor tissue, with a considerable improvement in the survival rate.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信